Novo Nordisk
NVO
552 hedge funds and large institutions have $8.82B invested in Novo Nordisk in 2017 Q4 according to their latest regulatory filings, with 104 funds opening new positions, 144 increasing their positions, 173 reducing their positions, and 41 closing their positions.
154% more first-time investments, than exits
New positions opened: 104 | Existing positions closed: 41
70% more call options, than puts
Call options by funds: $42.7M | Put options by funds: $25.1M
16% more capital invested
Capital invested by funds: $7.6B → $8.82B (+$1.23B)
12% more funds holding
Funds holding: 491 → 552 (+61)
12% more funds holding in top 10
Funds holding in top 10: 17 → 19 (+2)
0.67% more ownership
Funds ownership: 16.09% → 16.76% (+0.67%)
17% less repeat investments, than reductions
Existing positions increased: 144 | Existing positions reduced: 173
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$371M |
| 2 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$100M |
| 3 |
Renaissance Technologies
New York
|
+$69.7M |
| 4 |
CGT
Capital Guardian Trust
Los Angeles,
California
|
+$36.1M |
| 5 |
Fisher Asset Management
Camas,
Washington
|
+$29.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$92.9M |
| 2 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
-$47.1M |
| 3 |
CBT
Capital Bank & Trust
Irvine,
California
|
-$35.7M |
| 4 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$22.7M |
| 5 |
RRAM
River Road Asset Management
Louisville,
Kentucky
|
-$18.4M |
NVO Hedge Fund Activity: Q4 2017 in Review
552 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q4 2017, worth a combined $8.82B — up 16% from $7.6B a quarter earlier.
Buyers outnumbered sellers: 104 funds opened new NVO positions and 41 closed out — a net gain of 63 holders — while 144 added to existing stakes and 173 trimmed.
The largest buyer was BlackRock, adding an estimated $371M. The largest seller was Bank of America, cutting an estimated $92.9M.
- 552 institutional investors held Novo Nordisk (NVO) as of Q4 2017, up from 491 in Q3 2017.
- Funds reported $8.82B of Novo Nordisk stock for Q4 2017, up 16% quarter-over-quarter.
- 104 funds opened new Novo Nordisk positions in Q4 2017 and 41 closed out, a net change of +63 holders.
- The largest Novo Nordisk buyer in Q4 2017 was BlackRock, an estimated $371M added.
- The largest Novo Nordisk seller in Q4 2017 was Bank of America, an estimated $92.9M sold.
Based on aggregated 13F filings for Q4 2017.